Our research is driven by applying translational expertise to academic excellence through our collaborators and partners. We understand what it takes to successfully commercialize path-breaking discoveries into drugs that will change the lives of many patients worldwide.
Since 2009, we have filed over 28 patents and created an attractive portfolio of programs that are at different stages of the drug discovery and development process. Our multi-pronged approach empowers and ensures maximum utilization of our resources to provide access to unique and effective treatments.
Sphaera has adopted a target based approach instead of focusing on specific diseases and applications. Hence, our program selection is driven purely on scientific merits and is adaptable to the ever changing needs of the Pharma industry.